Educational Partnership: Updates in RA, PsA, and Biosimilars: A Pipeline View for the Clinical Nurse

Authors:

  • Linda Grinnell-Merrick, MS, NP-BC
  • Carrie Beach, BSN, RN-BC
  • Eileen Lydon, MA, RN, ANP-BC
  • Elizabeth Kirchner, MSN, CNP

CE Released: 12/26/2018
Valid for credit through: 12/26/2019

Accreditation Statement and Credits Available

Rheumatology Nurses Society is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation (Provider No. P0500).

Target Audience and Goal Statement

This activity is intended for rheumatology nurses and nurse practitioners.

The goal of this activity is to increase awareness in targeted treatments for rheumatoid arthritis (RA) and psoriatic arthritis (PsA), as well as the potential impact of biosimilar medicines in rheumatology clinical practice.

Upon completion of this activity, participants will be able to:

Have increased knowledge regarding the

  • New and emerging targeted therapies for the management of rheumatologic diseases
  • Potential impact of newer therapies in rheumatologic diseases on nursing practice

Please create an account for Medscape.com to continue and participate in the course.

Take Course